According to the analyst's market research, the sales value of Nifedipine in the Chinese market increased year by year from 2016 to 2019. In 2020, due to the impact of Covid-19 on the overall medical diagnosis and treatment services, the sales value of Nifedipine in the Chinese market fell to CNY730 million, and the CAGR of Nifedipine from 2016 to 2020 was 4.42%.
The analyst expects that with the relief of Covid-19, the sales value of Nifedipine in the Chinese market will have a restorative growth from 2021 to 2025. In addition, in recent years, nearly 20 million people worldwide died of cardiovascular and cerebrovascular diseases caused by hypertension and coronary heart disease each year. An estimated 300 million patients live with high blood pressure in China. As ageing of population in China becomes increasingly severe, the number and prevalence of patients are increasing year by year. Therefore, there is an increasing trend in sales volume of Nifedipine for the treatment of angina and hypertension. At the same time, compared with similar drugs, Nifedipine has longer action time, fewer doses, more stable blood concentrations, and less toxic and side effects. Based on these advantages, the sales volume and sales value of Nifedipine in the Chinese market will continue to grow from 2021 to 2025.
Topics Covered:
- The impact of COVID-19 on China's Nifedipine market
- Sales value of China's Nifedipine 2016-2020
- Competitive landscape of China's Nifedipine market
- Prices of Nifedipine in China
- Prices of Nifedipine in China by regions and manufacturers
- Analysis on factors affecting the development of China's Nifedipine market
- Prospect of China's Nifedipine market from 2021 to 2025
Table of Contents
Samples
LOADING...
Companies Mentioned
- Bayer AG (ADALAT)
- Shanghai Shyndec Pharmaceutical Co., Ltd. (Xinran)
- Qingdao Huanghai Pharmaceutical Co., Ltd. (Maikaofen)
- Beijing Honglin Pharmaceutical Co., Ltd. (Nifuda)
- Yangtze River Pharmaceutical Group Nanjing Hailing Pharmaceutical Co., Ltd.(Shansu)
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 50 |
Published | July 2021 |
Forecast Period | 2016 - 2025 |
Estimated Market Value ( CNY | CNY 613.65 Million |
Forecasted Market Value ( CNY | CNY 1285.86 Million |
Compound Annual Growth Rate | 8.5% |
Regions Covered | China |
No. of Companies Mentioned | 5 |